Dynamic Technology Lab’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-102,379
Closed -$11.8M – 1487
2023
Q3
$11.8M Buy
102,379
+99,280
+3,204% +$10.7M 1.18% 3
2023
Q2
$319K Buy
+3,099
New +$327K 0.04% 683
2022
Q3
– Sell
-23,330
Closed -$1.86M – 1674
2022
Q2
$1.86M Buy
+23,330
New +$2.21M 0.21% 115
2022
Q1
– Sell
-3,570
Closed -$385K – 1691
2021
Q4
$385K Buy
3,570
+637
+22% +$69.5K 0.04% 711
2021
Q3
$321K Buy
+2,933
New +$304K 0.04% 720
2021
Q2
– Sell
-2,186
Closed -$201K – 1734
2021
Q1
$201K Buy
+2,186
New +$184K 0.02% 957
2020
Q4
– Sell
-3,069
Closed -$238K – 1501
2020
Q3
$238K Buy
+3,069
New +$211K 0.04% 745
2019
Q3
– Sell
-14,569
Closed -$351K – 1446
2019
Q2
$351K Buy
14,569
+516
+4% +$13.1K 0.06% 571
2019
Q1
$371K Buy
+14,053
New +$333K 0.06% 558
2018
Q4
– Sell
-10,888
Closed -$213K – 1489
2018
Q3
$213K Buy
+10,888
New +$207K 0.03% 867
2018
Q2
– Sell
-44,472
Closed -$632K – 1497
2018
Q1
$632K Buy
+44,472
New +$657K 0.09% 390
2017
Q4
– Sell
-39,769
Closed -$505K – 1514
2017
Q3
$505K Buy
+39,769
New +$506K 0.08% 439

Other funds holding HZNP

Dynamic Technology Lab's HZNP Position: Q4 2023 in Review

Dynamic Technology Lab sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 102,379 shares — an estimated $11.8M sold.

Dynamic Technology Lab first reported a position in HZNP in Q3 2017 and held it in 12 quarters. The position peaked at $11.8M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Dynamic Technology Lab reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 102,379 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $11.8M.
  • Dynamic Technology Lab first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2017 and held it in 12 quarters.
  • Dynamic Technology Lab's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $11.8M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Dynamic Technology Lab's 13F filing for Q4 2023, filed 9 Feb 2024.